| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
| CD247 |
P20963
|
CD247 molecule
|
|
1.7E-02 |
0.539 |
0.731 |
| CD40LG |
P29965
|
CD40 ligand
|
Signaling
|
0.72 |
0.414 |
0.846 |
| CD55 |
P08174
|
CD55 molecule (Cromer blood group)
|
|
5.7E-12 |
0.510 |
0.808 |
| CD59 |
P13987
|
CD59 molecule (CD59 blood group)
|
|
0.61 |
0.469 |
0.808 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
| FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
| FCGR3A |
P08637
|
Fc fragment of IgG receptor IIIa
|
Cell adhesion
|
3.7E-06 |
0.432 |
0.962 |
| FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
| GATA1 |
P15976
|
GATA binding protein 1
|
|
0.95 |
0.483 |
0.808 |
| GPI |
P06744
|
glucose-6-phosphate isomerase
|
Enzyme
|
2.8E-06 |
0.491 |
0.769 |
| GSTK1 |
Q9Y2Q3
|
glutathione S-transferase kappa 1
|
|
1.9E-06 |
0.412 |
0.885 |
| HAMP |
P81172
|
hepcidin antimicrobial peptide
|
|
8.2E-03 |
0.433 |
0.846 |
| HFE |
Q30201
|
homeostatic iron regulator
|
|
2.6E-08 |
0.436 |
0.846 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| HP |
P00738
|
haptoglobin
|
Enzyme
|
1.7E-05 |
0.412 |
0.885 |
| HPGDS |
O60760
|
hematopoietic prostaglandin D synthase
|
|
1.8E-06 |
0.388 |
0.923 |
| IL17D |
Q8TAD2
|
interleukin 17D
|
|
0.20 |
0.464 |
0.808 |
| IL27 |
Q8NEV9
|
interleukin 27
|
|
0.78 |
0.457 |
0.808 |
| MYDGF |
Q969H8
|
myeloid derived growth factor
|
|
3.5E-06 |
0.451 |
0.846 |
| NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
| PIGA |
P37287
|
phosphatidylinositol glycan anchor biosynthesis class A
|
|
0.96 |
0.575 |
0.654 |
| PTPN22 |
Q9Y2R2
|
protein tyrosine phosphatase non-receptor type 22
|
|
3.5E-21 |
0.438 |
0.846 |